Month: August 2018

Pathologists Have Their ‘Carpe Diem’ Opportunity!

FOR MORE THAN TWO DECADES, leaders and forward-thinkers in the pathology profession bemoaned the fact that lab tests and anatomic pathology services were priced as commodities. From the podiums of various lab and healthcare conferences, they urged their peers to identify, document, and educate health insurers and others about the true value of lab tests. …

Pathologists Have Their ‘Carpe Diem’ Opportunity! Read More »

ProMedica, Sonic Form Lab Outreach Joint Venture

CEO SUMMARY: Fast-growing ProMedica Health System of Toledo, Ohio, agreed to a laboratory joint venture with Sonic Healthcare USA. As lab budgets and prices for lab tests are squeezed downward, ProMedica sees opportunity to add volume to this new core lab facility to improve efficiency and reduce costs per test. At the same time, it …

ProMedica, Sonic Form Lab Outreach Joint Venture Read More »

Sonic Sees a Future in Lab JVs with Hospitals

CEO SUMMARY: In every partnership, each member has a unique point of view. Following the announcement of a new laboratory joint venture company involving ProMedica Health System and Sonic Healthcare USA, the Sonic executive who worked with ProMedica’s administrators to develop the JV explained why Sonic is bullish on this hospital laboratory outreach joint venture …

Sonic Sees a Future in Lab JVs with Hospitals Read More »

Pathology Groups Should Act Now to Define Value

CEO SUMMARY: Payers and health system administrators generally agree that healthcare is moving away from fee-for-service toward value-based payment. Because adoption of value-based contracts is slower for pathologists than for other providers, pathologists have the opportunity to define how provider systems can pay for value contributed by pathologists. However, to take advantage of this opportunity, …

Pathology Groups Should Act Now to Define Value Read More »

FDA Issues Response to Draft Legislation to Regulate LDTs

DURING HER ADDRESS TO THE ANNUAL MEETING of the American Clinical Laboratory Association meeting in March, Rep. Diana DeGette (D-Colo.) explained why she and others in Congress had developed the Diagnostic Accuracy and Innovation Act (DAIA), a discussion draft that would give the FDA authority to regulate laboratory developed and in vitro diagnostic tests. At …

FDA Issues Response to Draft Legislation to Regulate LDTs Read More »

Anthem Alleges $16M in Calif. Hospital Lab Fraud

CEO SUMMARY: In a lawsuit filed in the U.S. District Court for the Central District of California, Anthem and affiliated Blue Cross Blue Shield plans alleged that 37-bed Sonoma West Medical Center, a Florida lab testing company, a medical billing company, and others used a pass-through lab test billing scheme to defraud Anthem and its …

Anthem Alleges $16M in Calif. Hospital Lab Fraud Read More »

August 20, 2018 Intelligence: Late Breaking Lab News

There is a new sector in the clinical laboratory industry. It is called “global direct-to-consumer (DTC) genetic health testing” by Kalorama Information, a market research firm based in Rockville, Md. In a recent report, Kalorama says this sector is comprised of the direct-to-consumer genetic tests which are initiated by the consumer, meaning that the consumer decides …

August 20, 2018 Intelligence: Late Breaking Lab News Read More »

Is the Joint Venture Hospital Lab an Emerging Trend?

CEO SUMMARY: THE DARK REPORT has uncovered a previously unnoticed trend that turns common wisdom on Wall Street upside down: Hospitals and health systems may be taking back control of their their laboratory outreach programs instead of selling them, and committing major resources to their inpatient labs instead of outsourcing their management. This joint venture …

Is the Joint Venture Hospital Lab an Emerging Trend? Read More »